Tag: radiopharmaceutical
Clarity and Nucleus RadioPharma scale up manufacturing for cancer treatment
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has entered into a Master Services Agreement (MSA) and Clinical Manufacturing Agreement for the production of 67Cu-SAR-bisPSMA, a radiopharmaceutical treatment for prostate cancer.
Australian pharma firm Telix opens $21m radiopharmaceutical production facility in Belgium
ASX-listed Telix Pharmaceuticals has recently opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility in Belgium, serving as the primary manufacturing site for radioisotopes and commercial and clinical products for patients in the Europe Middle East and Africa (EMEA) region.